8045 Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Proposed Rules 
2017 NAICS codes 2017 NAICS industry titles 
541713 .................................. Research and development in nanotechnology. 
541715 .................................. Research and development in the physical, engineering, and life sciences (except nanotechnology and bio-
technology. 
*******  
Artillery and Combat Vehicles Specialized Industry 
*******  
5173 ...................................... Wired and wireless telecommunications carriers. 
******* * 
Communications Specialized Industry 
*******  
5173 ...................................... Wired and wireless telecommunications carriers. 
*******  
Electronic Specialized Industry 
*******  
334613 .................................. Blank magnetic and optical recording media manufacturing. 
*******  
Guided Missiles Specialized Industry 
*******  
334613 .................................. Blank magnetic and optical recording media manufacturing. 
*******  
541713 .................................. Research and development in nonotechnology. 541715 .................................. Research and development in the physical, engineering, and life sciences (except nonotechnology and bio-
technology). 
*******  
Sighting and Fire Control Equipment Specialized Industry 
*******  
334613 .................................. Blank magnetic and optical recording media manufacturing. 
*******  
* * * * * 
[FR Doc. 2019–00798 Filed 3–5–19; 8:45 am] 
BILLING CODE 6325–39–P 
FEDERAL TRADE COMMISSION 
16 CFR Part 24 Guides for Select Leather and Imitation 
Leather Products 
AGENCY : Federal Trade Commission. 
ACTION : Regulatory review; request for 
public comment. 
SUMMARY : The Federal Trade 
Commission (‘‘FTC’’ or ‘‘Commission’’) requests public comments on its Guides for Select Leather and Imitation Leather Products (‘‘Leather Guides’’ or ‘‘Guides’’). The Commission is soliciting the comments as part of the Commission’s systematic review of all current Commission regulations and guides. 
DATES : Comments must be received by 
April 22, 2019. 
ADDRESSES : Interested parties may file a 
comment online or on paper by following the instructions in the Request for Comment part of the 
SUPPLEMENTARY INFORMATION section 
below. Write ‘‘Leather Guides Review, P188014’’ on your comment, and file your comment online at https://www.regulations.gov by following the 
instructions of that website. If you prefer to file your comment on paper, mail your comment to the following 
address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC– 5610 (Annex J), Washington, DC 20580; or deliver your comment to the following address: Federal Trade 
Commission, Office of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 610, Washington, DC 20024. 
FOR FURTHER INFORMATION CONTACT : 
James R. Golder (214–979–9376), jgolder@ftc.gov, Attorney, Southwest 
Region, Federal Trade Commission, 1999 Bryan Street, Suite 2150, Dallas, Texas 75201. 
SUPPLEMENTARY INFORMATION : 
VerDate Sep<11>2014 18:34 Mar 05, 2019 Jkt 247001 PO 00000 Frm 00003 Fmt 4702 Sfmt 4702 E:\FR\FM\06MRP1.SGM 06MRP18046 Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Proposed Rules 
1The Leather Guides ‘‘are administrative 
interpretations of laws administered by the 
Commission for the guidance of the public in conducting its affairs in conformity with legal requirements. They provide the basis for voluntary and simultaneous abandonment of unlawful practices by members of industry.’’ 16 CFR 1.5. Conduct inconsistent with the Guides may result in 
corrective action by the Commission under Section 5 of the FTC Act (15 U.S.C. 45). 
261 FR 51577 (October 3, 1996). When adopted, 
the Leather Guides consolidated portions of the Guides for the Luggage and Related Products Industry, the Guides for Shoe Content Labeling and Advertising, and the Guides for the Ladies’ Handbag Industry. The Leather Guides also included provisions previously contained in the Commission’s Trade Regulation Rule Concerning Misbranding and Deception as to Leather Content of Waist Belts. See 72 FR 28907 (May 23, 2007). 
372 FR 28906 (May 23, 2007). 
473 FR 34630 (June 18, 2008). I. Background 
The Commission’s Leather Guides 
address misrepresentations about the 
composition and characteristics of specific leather and imitation leather products.
1The Guides apply to the 
manufacture, sale, distribution, marketing, or advertising of all kinds of leather or simulated leather purses, luggage, wallets, footwear, and other similar products. Importantly, the Leather Guides state that disclosure of non-leather content should be made for material that has the appearance of leather but is not leather. 
The Commission adopted the Leather 
Guides in 1996, as part of its periodic review of its rules and guides.
2On May 
23, 2007, the Commission published a Federal Register notice seeking public comment on the Guides.
3On June 18, 
2008, the Commission published its conclusion that there was a continuing need for the Guides, and it approved retention of the Guides in their current form.
4 
II. Regulatory Review Program 
The Commission periodically reviews 
all Commission rules and guides. These reviews seek information about the costs and benefits of the Commission’s rules and guides and their economic impact. The information obtained assists the Commission in identifying rules and guides that warrant modification or rescission. Therefore, the Commission solicits comment on, among other things, the economic impact of and the continuing need for its Leather Guides; possible conflict between the Guides and state, local, federal, or international laws; and the effect of any technological, economic, environmental, or other industry changes on the Guides. 
III. Request for Comment 
The Commission is particularly 
interested in comments and supporting data on the following questions. These 
questions are designed to assist the public and should not be construed as a limitation on the issues on which public comment may be submitted. In their replies to each of these questions, commenters should provide any available evidence and data, such as empirical data, consumer perception studies, or consumer complaints, that support the commenter’s asserted position. 
(1) Is there a continuing need for the 
Leather Guides as currently promulgated? 
(2) Are any specific provisions of the 
Leather Guides no longer necessary? 
(3) Are the deceptive or unfair 
practices addressed by the Leather Guides prevalent in the marketplace? 
Are the Guides effective in addressing those practices? 
(4) Are there deceptive or unfair 
practices in the selling of leather or imitation leather products in other industries that are not covered by the Leather Guides, such as automotive and furniture upholstery products? If so, what is the extent of misrepresentations in those industries? How do consumers interpret or perceive the appearance of leather or simulated leather in those industries? Should the Commission expand the Guides to cover these or other products? What compliance costs would be imposed on these industries if the Commission were to expand the Guides? Are there any special considerations for those industries? Are there alternatives, such as individual enforcement actions under the FTC Act, that would be more effective or equally effective in addressing those practices? 
(5) Have covered businesses adopted 
the Leather Guides as part of their routine business practice? Have uncovered businesses adopted the Leather Guides as part of their routine business practice? What is the degree of compliance with the Guides? How, and what effect, if any, does this have on the continuing need for the Guides? Do covered or uncovered businesses self- regulate or have voluntary standards or guidance, such as through trade associations, which overlap with the Guides? 
(6) What benefits, if any, have the 
Leather Guides provided to consumers of the products affected by the Guides? Do the Guides impose any significant costs on consumers? 
(7) What impact, if any, have the 
Leather Guides had on the flow of truthful or deceptive information to consumers? 
(8) What changes, if any, should be 
made to the Leather Guides to increase their benefits to consumers? How would these changes affect consumer benefits 
or business costs? 
(9) What burdens or costs, including 
costs of compliance, have the Leather Guides imposed on covered businesses? What burdens or costs have the Guides imposed on small businesses in particular? Have the Guides provided benefits to businesses? If so, what benefits? 
(10) What changes, if any, should be 
made to the Leather Guides to reduce 
the burdens or costs imposed on businesses? How would these changes affect consumer benefits or business costs? 
(11) Do the Leather Guides overlap or 
conflict with federal, state, or local laws or regulations? Do the Guides overlap or conflict with any international laws or regulations? 
(12) Have consumer perceptions 
changed since the Leather Guides were issued and, if so, do these changes warrant revising the Guides? 
(13) Since the Leather Guides were 
issued, what effects, if any, have changes in relevant technological, economic, or environmental conditions had on the need for or usefulness of the Guides? 
You can file a comment online or on 
paper. For the Commission to consider your comment, we must receive it on or before April 22, 2019. Write ‘‘Leather Guides Review, P188014’’ on your comment. Your comment—including your name and your state—will be placed on the public record of this proceeding at https://wwwregulations.gov. 
Postal mail addressed to the 
Commission is subject to delay due to heightened security screening. As a result, we encourage you to submit your comments online. To ensure the Commission considers your online comment, you must file it at http://www.regulations.gov by following the 
instructions of that website. 
If you file your comment on paper, 
write ‘‘Leather Guides Review, P188014’’ on your comment and on the envelope, and mail it to the following address: Federal Trade Commission, Office of the Secretary, 600 Pennsylvania Avenue NW, Suite CC– 5610 (Annex J), Washington, DC 20580; or deliver your comment to the following address: Federal Trade Commission, Office of the Secretary, Constitution Center, 400 7th Street SW, 5th Floor, Suite 5610, Washington, DC 20024. If possible, please submit your paper comment to the Commission by courier or overnight service. 
Because your comment will be placed 
on a publicly accessible website at https://www.regulations.gov, you are 
VerDate Sep<11>2014 18:34 Mar 05, 2019 Jkt 247001 PO 00000 Frm 00004 Fmt 4702 Sfmt 4702 E:\FR\FM\06MRP1.SGM 06MRP18047 Federal Register / Vol. 84, No. 44 / Wednesday, March 6, 2019 / Proposed Rules 
solely responsible for making sure that 
your comment does not include any sensitive personal information, such as your or anyone’s Social Security number; date of birth; driver’s license number or other state identification number or foreign country equivalent; passport number; financial account number; or credit or debit card number. You are also solely responsible for ensuring your comment does not include any sensitive health information, such as medical records or other individually identifiable health information. In addition, your comment should not include any ‘‘[t]rade secret or any commercial or financial information which . . . is privileged or confidential’’—as provided in Section (f) of the FTC Act, 15 U.S.C. 46(f), and FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)— including in particular competitively sensitive information such as costs, sales statistics, inventories, formulas, patterns, devices, manufacturing processes, or customer names. 
Comments containing material for 
which confidential treatment is requested must be filed in paper form, must be clearly labeled ‘‘Confidential,’’ and must comply with FTC Rule 4.9(c). In particular, the written request for confidential treatment that accompanies the comment must include the factual and legal basis for the request, and must identify the specific portions of the comment to be withheld from the public record. See FTC Rule 4.9(c). Your 
comment will be kept confidential only if the General Counsel grants your request in accordance with the law and the public interest. Once your comment has been posted publicly—as legally required by FTC Rule 4.9(b)—we cannot redact or remove your comment from the www.regulations.gov website, unless 
you submit a confidentiality request that meets the requirements for such treatment under FTC Rule 4.9(c), and the General Counsel grants that request. 
Visit the FTC website to read this 
Notice and the news release describing it. The FTC Act and other laws that the Commission administers permit the collection of public comments to consider and use in this proceeding as appropriate. The Commission will consider all timely and responsive public comments that it receives on or before April 22, 2019. For information on the Commission’s privacy policy, including routine uses permitted by the Privacy Act, see https://www.ftc.gov/ site-information/privacy-policy. By direction of the Commission. 
April Tabor, 
Acting Secretary. 
[FR Doc. 2019–03970 Filed 3–5–19; 8:45 am] 
BILLING CODE 6750–01–P 
DEPARTMENT OF HEALTH AND 
HUMAN SERVICES 
Food and Drug Administration 
21 CFR Part 864 
[Docket No. FDA–2018–N–4394] 
Medical Devices; Exemption From 
Premarket Notification: Class II Devices; Flow Cytometer Instruments; Request for Comments 
AGENCY : Food and Drug Administration, 
HHS. 
ACTION : Proposed order; request for 
comments. 
SUMMARY : The Food and Drug 
Administration (FDA or Agency) is announcing its intention to exempt certain flow cytometer instruments from premarket notification requirements, subject to conditions and limitations. The Agency has determined based on established factors that these devices, which are currently regulated by FDA under product code OYE, no longer require premarket notification to provide reasonable assurance of safety and effectiveness. All other class II devices classified under FDA’s automated differential cell counter regulation would continue to be subject to premarket notification requirements. FDA is publishing this proposed order to obtain comments regarding this proposed exemption, in accordance with the Federal Food, Drug, and Cosmetic Act (FD&C Act). 
DATES : Submit either electronic or 
written comments on the notice by May 6, 2019. 
ADDRESSES : You may submit comments 
as follows. Please note that late, untimely filed comments will not be considered. Electronic comments must be submitted on or before May 6, 2019. The https://www.regulations.gov 
electronic filing system will accept comments until midnight Eastern Time at the end of May 6, 2019. Comments received by mail/hand delivery/courier (for written/paper submissions) will be considered timely if they are 
postmarked or the delivery service acceptance receipt is on or before that date. 
Electronic Submissions 
Submit electronic comments in the 
following way: •Federal eRulemaking Portal: 
https://www.regulations.gov. Follow the 
instructions for submitting comments. 
Comments submitted electronically, including attachments, to https://www.regulations.gov will be posted to 
the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. 
•If you want to submit a comment 
with confidential information that you 
do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). 
Written/Paper Submissions 
Submit written/paper submissions as 
follows: 
•Mail/Hand delivery/Courier (for 
written/paper submissions): Dockets 
Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. 
•For written/paper comments 
submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ 
Instructions: All submissions received 
must include the Docket No. FDA– 2018–N–4394 for ‘‘Medical Devices; Exemptions from Premarket Notification: Class II Devices; Flow Cytometer Instruments; Request for Comments.’’ Received comments, those filed in a timely manner (see 
ADDRESSES ), will be placed in the docket 
and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. 
•Confidential Submissions—To 
submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS 
VerDate Sep<11>2014 18:34 Mar 05, 2019 Jkt 247001 PO 00000 Frm 00005 Fmt 4702 Sfmt 4702 E:\FR\FM\06MRP1.SGM 06MRP1